Labcorp Holdings Inc. · NYSE:LH
Labcorp — Laboratory Corp of America Holdings — Merger or Acquisition (July 2017)
8 slides from Labcorp's merger presentation, Jul 31, 2017
Slide 1: LabCorp to Acquire Chiltern
LabCorp to Acquire Chiltern Advancing Our Global Leadership ' In’Drug Development July 32, 2037 CHILTERN
Slide 2: Forward Looking Statements
Forward Looking Statements tothe lieve, “project” “expect.” “anticipate “strategy,” future.” “opportunity,” “pla would," “wil be,” “will nue, “wi id other statements. sl : ca me sat : y ect Lab« price of Gi transact (i) change or pendency (tisk Ct hiltern b i i) the ability of LabCorp to 4 4 a cl ft
Slide 3: Key Transaction Highlights
Key Transaction Highlights Transaction Value Transaction Impact Financing Timing Enterprise value of $1.2 billion Expected Chiltern revenue of approximately $550 million in 2017 Expected Chiltern adjusted EBITDA of approximately $95 million in 2017 Accretive to adjusted EPS and free cash flow in yea
Slide 4: Chiltern: A Leading CRO Among Emerging and Mid-Market Biopharma Customers
Chiltern: A Lea ig CRO Among Emerging and Mid-Market Biopharma Customers Broad-Based and Highly Flexible Service Offering (FSP, Full-Service and eClinical) «+ Tlored solutions for high-growth emerging and mid-market ( | biophaems customers 1 Focused on full-service global clinical development ‘Provi
Slide 5: Differentiated Player
and cov. CE.\+ Cus ting Differentiated Player 9,100 employees in the Americas, ~5,300 employees in the Americas, 2,100 ‘employees in the Americas, ~7,100 in in Europe and ~1,700 in Asia-Pacific _ in Europe and ~700 in APAC Europe and ~2,400 in APAC P Presence in th id mid customer segment segments B
Slide 6: Expands Global Footprint
xpands hae Footprint, | ities in Asia-Pacific Region Over 20,000 CRO Employees Worldwide Europe, Middle The Americas East, & Africa Covance: ~9,100 Chiltern: Combined: ,000 ~11,100
Slide 7: Combination Broadens Customer Base and Reinforces Broad Therapeutic Expertise
Combinati .< Base and Reinforces Broad Therapeutic Expertise . Highly complementary customer base positions ~ Sr pna tte ops sephoma rowth se nt with expanded presencein the tigh rot ‘emerging and mid-market biopharma segment « Diverse customer base with no single customer representing more than 10%
Slide 8: A Compelling Combination
A Compelling Combination ZI Enhances customer offering to include a dedicated focus on the high-growth emerging and mid-market biopharma segments YI Deepen: i with i ip in oncology, to provide janovatve solutions for customers’ most perpeah problems across the healthcare ecosystem Increases global s
Laboratory Corp of America Holdings — Merger or Acquisition (July 2017) on 6ix